MTEX vs TRLV
Mannatech Inc. and Trulieve Cannabis Corp., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | MTEX | TRLV |
|---|---|---|
| Revenue | $108.0M | $1.2B |
| Net income | $-15.2M | $-122.2M |
| Gross margin | 74.9% | 60.2% |
| Net margin | −14.1% | −10.3% |
| Return on equity | −897.3% | — |
| Diluted EPS | −$8.00 | −$0.58 |
| Dividend / share | $0.20 | — |
| Payout ratio | 0.0% | — |
| Free cash flow | $-4.3M | $228.6M |
| Equity | $-5.2M | — |
| Net debt / equity | −0.97× | — |
| Current ratio | 1.10× | 4.43× |
| Revenue CAGR 5y | −6.5% | 17.8% |
| Profit CAGR 5y | — | — |
TRLV bills 10.9× the revenue of MTEX, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
7 years side by side
| Fiscal year | MTEX | TRLV |
|---|---|---|
| FY2025 | $108.0M | $1.2B |
| FY2024 | $117.9M | $1.2B |
| FY2023 | $132.0M | $1.1B |
| FY2022 | $137.2M | $1.2B |
| FY2021 | $159.8M | $931.9M |
| FY2020 | $151.4M | $521.5M |
| FY2019 | $157.7M | $252.8M |
Net income by year
Bottom line
| Fiscal year | MTEX | TRLV |
|---|---|---|
| FY2025 | $-15.2M | $-122.2M |
| FY2024 | $2.5M | $-160.6M |
| FY2023 | $-2.2M | $-533.1M |
| FY2022 | $-4.5M | $-252.7M |
| FY2021 | $9.8M | $17.4M |
| FY2020 | $6.3M | $63.0M |
| FY2019 | $3.3M | $53.1M |
Advertisement
AdSense · Rectangle 336×280
More in this industry